Catalyst Wire Dossier Catalyst Wire Dossier

Avanz Phleum Pratense

Phleum pratense pollen allergen extract · ALK-Abelló A/S
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Avanz Phleum Pratense, covering 2014-01-22 to 2016-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber [Phase 2]

See pricing